Journal of Infectious Diseases
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection
2016
-
Is Surveillance for Multidrug‐Resistant Enterobacteriaceae an Effective Infection Control Strategy in the Absence of an Outbreak?
2002
-
Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited by Inactivated and Live Attenuated Vaccines in Children..
jiae489.
2024
-
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study.
230:e847-e859.
2024
-
Effectiveness of Influenza Vaccination During Pregnancy Against Laboratory-Confirmed Seasonal Influenza Among Infants Under 6 Months of Age in Ontario, Canada.
230:e80-e92.
2024
-
Effectiveness of Influenza Vaccination During Pregnancy Against Laboratory-Confirmed Seasonal Influenza Among Infants Under 6 Months of Age in Ontario, Canada..
230:e80-e92.
2024
-
Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease.
230:239-249.
2024
-
Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease..
230:239-249.
2024
-
Natural Killer Cell-Derived Interferon-γ Regulates Macrophage-Mediated Immunopathology During Viral Infection.
228:834-839.
2023
-
An Assessment of National Strategic Action Plans for Viral Hepatitis Elimination, 2016–2021.
228:S148-S153.
2023
-
Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants.
227:1333-1334.
2023
-
Effectiveness and Duration of Protection of a Fourth Dose of Coronavirus Disease 2019 Messenger RNA Vaccine Among Long-term Care Residents in Ontario, Canada.
227:977-980.
2023
-
Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020.
225:768-776.
2022
-
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor–Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
224:377-388.
2021
-
Genomic Epidemiology of Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Hospitalized Individuals in Ontario, Canada.
222:2071-2081.
2020
-
Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults.
222:428-437.
2020
-
Repeated Seasonal Influenza Vaccination: How Much Is Too Much of a Good Thing?.
222:173-175.
2020
-
Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
221:42-52.
2020
-
Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles.
220:S91-S98.
2019
-
Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation.
220:1355-1366.
2019
-
Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes.
218:1722-1729.
2018
-
Kinetics of Serological Responses in Critically Ill Patients Hospitalized With 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009–2011.
217:1078-1088.
2018
-
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
216:405-414.
2017
-
Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents.
216:191-197.
2017
-
Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.
216:135-145.
2017
-
Immunogenicity of Varicella Vaccine and Immunologic Predictors of Response in a Cohort of Elderly Nursing Home Residents.
214:1905-1910.
2016
-
Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.
214:1996-2005.
2016
-
Autoimmune VariantPTPN22C1858T Is Associated With Impaired Responses to Influenza Vaccination.
214:248-257.
2016
-
Medroxyprogesterone Acetate Regulates HIV-1 Uptake and Transcytosis but Not Replication in Primary Genital Epithelial Cells, Resulting in Enhanced T-Cell Infection.
211:1745-1756.
2015
-
Evaluation of HIV and Highly Active Antiretroviral Therapy on the Natural History of Human Papillomavirus Infection and Cervical Cytopathologic Findings in HIV-Positive and High-Risk HIV-Negative Women.
208:454-462.
2013
-
1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans.
207:98-105.
2013
-
Longitudinal Study of Influenza Molecular Viral Shedding in Hutterite Communities.
206:1078-1084.
2012
-
Critical Role of Natural Killer Cells in Lung Immunopathology During Influenza Infection in Mice.
206:167-177.
2012
-
Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Female Genital Tract After Simulated Vaginal Intercourse.
205:725-732.
2012
-
Genetic Variants and Susceptibility to Neurological Complications Following West Nile Virus Infection.
204:1031-1037.
2011
-
Endometrial Epithelial Cell Responses to Coinfecting Viral and Bacterial Pathogens in the Genital Tract Can Activate the HIV-1 LTR in an NFκB-and AP-1–Dependent Manner.
204:299-308.
2011
-
Ability to Replicate in the Cytoplasm Predicts Zoonotic Transmission of Livestock Viruses.
199:565-568.
2009
-
Bacterial Genetic Determinants of Non‐O157 STEC Outbreaks and Hemolytic‐Uremic Syndrome after Infection.
194:819-827.
2006
-
Low CD4 T Cell Counts before HIV‐1 Seroconversion Do Not Affect Disease Progression in Ethiopian Factory Workers.
192:739-748.
2005
-
Toll‐Like Receptor (TLR)–3, but Not TLR4, Agonist Protects against Genital Herpes Infection in the Absence of Inflammation Seen with CpG DNA.
190:1841-1849.
2004
-
Diagnostic and Prognostic Implications of Endotoxemia in Critical Illness: Results of the MEDIC Study.
190:527-534.
2004
-
Transmission of Herpes Simplex Virus Type 2 among Factory Workers in Ethiopia.
190:365-372.
2004
-
An Outbreak of Trichinellosis Due to Consumption of Bear Meat Infected withTrichinella nativa,in 2 Northern Saskatchewan Communities.
188:835-843.
2003
-
Limited Protective Effect of the CCR5Δ32/CCR5Δ32 Genotype on Human Immunodeficiency Virus Infection Incidence in a Cohort of Patients with Hemophilia and Selection for Genotypic X4 Virus.
187:215-225.
2003
-
Laboratory Characterization of Methicillin‐ResistantStaphylococcus aureusin Canadian Hospitals: Results of 5 Years of National Surveillance, 1995–1999.
186:652-660.
2002
-
Chlamydia pneumoniaeInfection of Endothelial Cells Induces Transcriptional Activation of Platelet‐Derived Growth Factor–B: A Potential Link to Intimal Thickening in a Rabbit Model of Atherosclerosis.
185:1621-1630.
2002
-
Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial.
183:392-400.
2001
-
Factors Contributing to the Lack of Human Immunodeficiency Virus Type 1 (HIV‐1) Transmission in HIV‐1–Discordant Partners.
182:123-132.
2000
-
RANTES Production by T Cells and CD8‐Mediated Inhibition of Human Immunodeficiency Virus Gene Expression before Initiation of Potent Antiretroviral Therapy Predict Sustained Suppression of Viral Replication.
181:505-512.
2000
-
Atovaquone Suspension Compared with Aerosolized Pentamidine for Prevention ofPneumocystis cariniiPneumonia in Human Immunodeficiency Virus–Infected Subjects Intolerant of Trimethoprim or Sulfonamides.
180:369-376.
1999
-
Serum Antibodies toBalamuthia mandrillaris,a Free‐Living Amoeba Recently Demonstrated to Cause Granulomatous Amoebic Encephalitis.
179:1305-1308.
1999
-
Receptor Affinity Purification of a Lipid-Binding Adhesin from Haemophilus influenzae.
175:77-83.
1997
-
Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after Revaccination.
172:1591-1595.
1995
-
-Actinin Accumulation in Epithelial Cells Infected with Attaching and Effacing Gastrointestinal Pathogens.
172:1393-1396.
1995
-
Diagnosis Of Chlamydia Trachomatis Urethral Infection In Symptomatic And Asymptomatic Men By Testing First-Void Urine In A Ligase Chain Reaction Assay.
170:1308-1311.
1994
-
Maternal Measles and Rubella Antibody Levels and Serologic Response in Infants Immunized with MMR II Vaccine at 12 Months of Age.
168:1596-1598.
1993
-
Mucosal Immunity and Protection after Intranasal Immunization with Recombinant Adenovirus Expressing Herpes Simplex Virus Glycoprotein B.
168:622-629.
1993
-
Comparison of Cervical, Urethral, and Urine Specimens for the Detection of Chlamydia trachomatis in Women.
164:205-208.
1991
-
A Recombinant Human Adenovirus Vaccine against Rabies.
161:27-30.
1990
-
Detection of Chlamydia trachomatis Antigens in Urine as an Alternative to Swabs and Cultures.
161:124-126.
1990
-
Once-Daily Therapy with Ceftriaxone Compared with Daily Multiple-Dose Therapy with Cefotaxime for Serious Bacterial Infections: A Randomized, Double-Blind Study.
160:433-441.
1989
-
LYMPHOCYTE-T IN GENITAL LYMPH-NODES PROTECT MICE FROM INTRAVAGINAL INFECTION WITH HERPES-SIMPLEX VIRUS TYPE-2.
159:460-466.
1989
-
T Lymphocytes in Genital Lymph Nodes Protect Mice from Intravaginal Infection with Herpes Simplex Virus Type 2.
159:460-466.
1989
-
Clinical Significance of a Test for Slime Production in Ventriculoperitoneal Shunt Infections Caused by Coagulase-Negative Staphylococci.
156:555-560.
1987
-
Detection of Chlamydia trachomatis Antigens by Enzyme Immunoassay and Immunofluorescence in Genital Specimens from Symptomatic and Asymptomatic Men and Women.
154:141-148.
1986
-
Stool Survey for Escherichia coli O157:H7.
153:1176-1176.
1986
-
Elevated Levels of Interferon-Induced 2'-5' Oligoadenylate Synthetase in Generalized Persistent Lymphadenopathy and the Acquired Immunodeficiency Syndrome.
152:466-472.
1985
-
A Nosocomial Outbreak of Diarrheal Disease Due to Yersinia enterocolitica Serotype 0:5, Biotype 1.
145:242-247.
1982
-
Congenital Cytomegalovirus Infection in an Urban Canadian Community.
142:647-653.
1980
-
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on new and useful techniques in rapid viral diagnosis..
142:793-802.
1980
-
Summary of a Workshop on New and Useful Techniques in Rapid Viral Diagnosis.
142:793-802.
1980
-
Summary of a Workshop on New and Useful Methods in Viral Diagnosis.
138:414-419.
1978
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)